Vytorin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
Condition:   Hypercholesterolemia, Dyslipidemia Interventions:   Drug: Ezetimibe/Atorvastatin 10/5 mg;   Drug: Atorvastatin 5mg;   Drug: Ezetimibe 10mg;   Drug: Atorvastatin 10mg;   Drug: DW1125 placebo;   Drug: DW1125A placebo;   Drug: DW1125E placebo;   Drug: DW1125A-1 placebo Sponsor:   Daewon Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Conditions:   Essential Hypertension;   Primary Hypercholesterolemia Interventions:   Drug: Fimasartan;   Drug: Ezetimibe/Atorvastatin;   Drug: Fimasartan Placebo;   Drug: Ezetimibe/Atorvastatin Placebo Sponsor:   Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials